Huaxi Biotechnology: It is expected that the net profit will increase by 54.93% to 83.63% in 2025 compared to the previous year.

Huaxi Biotechnology announced that it is expected to achieve a net profit attributable to the owners of the parent company of RMB 270 million to 320 million in 2025. Compared with the same period of the previous year, it will increase by RMB 957.326 million to 1,457.326 million, an increase of 54.93% to 83.63% year-on-year. The net profit attributable to the owners of the parent company in the same period of the previous year was RMB 1742.674 million, and the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was RMB 1072.720 million. The smaller base led to a large fluctuation in the company's performance.